Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 100c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $85.42 +0.06%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
VIVO, PMCB, PLCE, More
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($1.39), $1.00 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $74.42 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Subaru, other Japan suppliers to team on delivery as Boeing raises output - Nikkei
- Climb Bio (CLYM) PT Raised to $25 at Baird
- Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
